News

The Centers for Medicare & Medicaid Services sent to each state letters regarding compliance with federal requirements related to automatic eligibility renewals, known as “ex parte” renewals, under Medicaid and the Children’s Health Insurance Program.

July saw the continued worsening of hospitals’ finances, according to a new Kaufman Hall report.

A three-judge panel in federal court last week partially revived a class action lawsuit against UnitedHealth Group subsidiary United Behavioral Health, reversing an earlier decision from 2020.

AHA Aug. 28 supported the Centers for Medicare & Medicaid Services’ proposal to change how certain forms of noncomprehensive coverage can be marketed and sold.

AHA responded to the Centers for Medicare & Medicaid Services’ calendar year 2024 proposed rule for the home health prospective payment system by voicing its extreme concern with the overall net negative update.

In an Aug. 28 letter to House sponsors, the AHA voiced support for the GOLD Card Act of 2023 (H.R. 4968) that would exempt qualifying providers from prior authorization requirements under Medicare Advantage plans.

The Department of Health and Human Services announced the first list of Medicare Part D drugs subject to price negotiations, a tenet of the Inflation Reduction Act designed to reduce health care costs.

The U.S. District Court for the Eastern District of Texas for a third time ruled to set aside certain regulations implementing the No Surprises Act.

Deanna Martin, AHA’s vice president for professional membership groups, highlights the valuable insights to be gained by marketing, communications and business development professionals who take part in the upcoming Society for Health Care Strategy & Market Development’s annual Connections Conference Sept. 10-12 in Chicago.

In the post-COVID-19 pandemic era, health care leaders are finding new ways to strengthen performance through innovative approaches, while improving care, quality and patient safety. Hear how Johns Hopkins is using innovation to ensure long-term financial stability while managing day-to-day struggles.

In time for back-to-school health screenings, AHA Aug. 25 released an infographic on strategies that clinicians and the Centers for Disease Control and Prevention have employed to encourage COVID-19 vaccinations among children.

The Centers for Medicare & Medicaid Services Aug. 25 reported that the Medicare Shared Savings Program saved the agency $1.8 billion in 2022. This marks the sixth consecutive year of cost savings for the program, and the second highest savings year reported since the program started.

Draeger Medical, Inc. is recalling its Carina Ventilators due to the presence of contaminants in the device’s airpath, which exceed acceptable levels if used by pediatric patients for more than 30 days.

A new study by Business Group on Health reveals that, amid increases in the percentage of health care dollars spent on pharmacy, 92% of employers are concerned about high-cost drugs in the pipeline, with 91% reporting concern about pharmacy cost trends overall.

The Centers for Disease Control and Prevention Aug. 24 announced the launch of its Hospital Sepsis Program Core Elements initiative, a new program to provide hospitals with a blueprint to managing medical emergencies stemming from sepsis

Fisher-Titus' Stacy Daniel, director of clinical programs, and Katie Chieda, chief nursing officer, discuss their approach to recruiting international nurses to their community to ensure they remain a strong, independent health system for years to come.

AHA Board Chair John Haupert is among those named to the Congressional Budget Office’s 2023 Panel of Health Advisers, it was announced recently.

A new resource from the Cybersecurity and Infrastructure Security Agency, National Security Agency and the National Institute of Standards and Technology is helping hospitals and other critical infrastructure organizations get up to speed on the impacts of quantum capabilities in cybersecurity and assist their early planning for migration to post-quantum cryptographic standards.

The Delaware Hospital Association Aug. 18 named Brian Frazee as its new president and CEO. Prior to joining DHA, Frazee was with the Maryland Hospital Association, where he served as vice president of government affairs.    

The Food and Drug Administration announced its approval of Pfizer’s Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease and severe LRTD caused by respiratory syncytial virus in infants from birth through six months of age.